Please login to the form below

Not currently logged in
Email:
Password:

X4 appoints John Celebi as COO

He joins from Igenica Biotherapeutics

X4 Pharmaceuticals John CelebiCambridge, Massachusetts-based X4 Pharmaceuticals has appointed John Celebi as its new chief operating officer.

Celebi brings over 20 years of biotech industry experience to the role, and will take on responsibility for X4's business development, operations and corporate development.

Most recently, he served as chief business officer of Igenica Biotherapeutics, and has previously held senior positions at Agilent Technologies, ArQule, Biogen and Cyclis Pharmaceuticals.

Paula Regan, president and chief executive of X4, said: “John has a tremendous knowledge-base for evolving an emerging biotech company across the range of critical business capabilities.

“His experience will be essential to achieving X4's mission of developing novel CXCR4 therapies that have the potential to make a significant impact in the cancer treatment landscape, and we look forward to tapping into his business-building expertise as we continue to pursue the development of X4P-001 and our portfolio of CXCR4 inhibitors.”

22nd June 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
COUCH Health

We are a patient engagement agency committed to making clinical study experiences human. By guiding organisations in making everything they...

Latest intelligence

Patient engagement
Taking a holistic approach to patient care
The importance of recognising each patient as an individual...
The concordance conundrum – the tech divide
“Hello? Can you hear me? I think you are on mute” – how many times have we all heard this over the past five or so months? Not exactly the...
3 ways to increase patient retention rates in clinical trials
Retention rates are falling in clinical trials. Yes, it is a bit disheartening. But there are some straightforward things you can do to turn it around....

Infographics